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Abstract
The supragingival plaque control need has been sustained by the concept of the periodontal 
disease as an opportunistic infection. This concept relies on the fact that the supragingival biofilm 
has been proven to be essential for the establishment of the subgingival biofilm, this opportunity 
arising through a retro-feeding process between the supragingival biofilm formation and 
maturation and the inflammatory response. Since decades, the impact of the supragingival 
plaque control has been recognized as an important factor to modulate the subgingival response, 
regarding clinical, microbiological, and immunological indicators. These studies collectively 
underscore the supragingival control as essential not only for prevention of periodontal disease 
and maintenance of therapy results but also for the treatment of periodontitis, favoring 
subgingival inflammation reduction as well as the stability of attachment levels. Thus, it can be 
concluded that an adequate supragingival control is essential for the quality of periodontal 
therapy, migrating from a second-plan intervention to a unique unquestionable importance.
ABBREVIATIONSPPD: Periodontal Probing Depth; PFZ: Plaque Free Zone; 
SPG: Supragingival Biofilm Control; BOP: Bleeding on Probing; 
SRP: Scaling and Root Planning; CAL: Clinical Attachment Loss; 
PMP: Periodontal Maintenance Period; PRA: Periodontal Risk 
Assessment
INTRODUCTION
Since the classic experimental study by Löe et al., in 1965 
[1], evaluating the consequences of the establishment and 
control of the supragingival biofilm over the marginal soft-tissue 
inflammation, gingivitis has gained attention. These observations 
collectively with the comprehension that gingivitis precedes 
periodontitis consolidated the supragingival conditions as central 
in the periodontal field [2,3]. This subject became renowned due 
to a series of publications from the 11° European Workshop in 
Periodontology, when gingivitis was consolidated as important 
in not only the prevention and maintenance of therapeutic results 
but also for the treatment of periodontitis [4]. Since decades, 
different authors have carried out studies that pointed out to the 
same direction [5-12].
In particular, the relevance of the supragingival environment 
over the subgingival one is supported by the understanding 
of the influence it has on the formation and modulation of the 
subgingival microbiota [13,14]. Accordingly, supragingival 
biofilm accumulation causes an initial marginal inflammatory 
response that increases the gingival revicular fluid flow, local 
edema, and marginal bleeding. Besides providing host-defenses 
components, those alterations propitiate metabolic substrates 
and important growth factors for anaerobic and proteolytic 
bacteria. While an increase in the periodontal probing depth 
(PPD) occurs due to edema, the depletion of oxygen and 
production of carbon/hydrogen dioxides by bacteria maintain 
an anaerobic environment. Additionally, bacterial metabolism 
promotes reduced pH and temperature elevations that are 
essential for competitiveness and aggressiveness of some 
species. As consequence, a simultaneous shift to a biofilm with 
anaerobic, proteolytic, and Gram-negative species occurs, 
while an increase in the total bacterial load is also observed 
[14,15]. Consequently, there is a greater challenge to the host, 
that responds by increasing the inflammatory response, retro-
feeding the process [13,16]. To a certain extent the studies on 
plaque free zone (PFZ) [17-22] encompass this subject. The first 
publication from Weidlich et al. [19], showed that after a period 
of supragingival biofilm formation (96 h), a plaque free zone 
disappears while an increase in inflammatory response is seen, 
propitiating the so-called ideal conditions for subgingival biofilm 
establishment, growth, and maturation. These observations are 
in accordance with the concept of periodontal disease as an 
opportunist infection [13,14], which emphasizes the beginning 
of the supragingival biofilm accumulation with a domain of 
Gram-positive aerobic saccharolytic bacteria, which evolves 
with time, to that dominated by Gram-negative, anaerobic, 
and asaccharolytic species, this shift being simultaneous to the 
inflammatory process and vice-versa. Under this comprehension, 
considering the role of the retro-feeding process between bacteria 
and inflammatory conditions, a series of studies was developed 
in order to better understand and to confirm the relevance of the 
gingivitis control [10-12,23-25].
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RESULTS AND DISCUSSION In 2007, a single-arm clinical trial was performed including 50 participants [10]. For a time period of 180 days, moderate-to-severe periodontitis patients received weekly appointments for 
supragingival biofilm control (SPG) and oral health instructions. 
The results showed that the SPG alone was able to significantly 
reduce the percentage of sites containing the presence of 
supragingival biofilm and gingivitis, as expected; it also reduced 
the percentage of sites that revealed bleeding on probing (BOP) 
and the PPD mean values. Interestingly, it was observed that no 
participant lost periodontal attachment during the entire period. 
Nevertheless, the study published in 2014 [12] corroborated 
those results. Over a split-mouth clinical trial design, 25 patients 
with chronic periodontitis received, per quadrant, one of the 
following treatment protocols: 1) only SPG (1 quadrant); 2) SPG, 
scaling and root planing (SRP), simultaneously (2 quadrants); 
and 3) SPG at day 0 and SRP (1 quadrant) 30 days after. The 
study was conducted over 450 days, during which the patients 
were reevaluated and administered oral hygiene orientations 
without subgingival approach (2.2 ± 1.64 months interval). The 
authors observed that the three treatment protocols propitiated 
significant changes on supragingival biofilm and gingivitis levels, 
as well as reductions in PPD, BOP, and clinical attachment loss 
(CAL). As presumed, greater reductions in subgingival indicators 
occurred on quadrants that received subgingival interventions. 
Alternatively, the authors highlighted that considering the need 
of subgingival intervention as a result of the presence of CAL plus 
BOP, the need of subgingival intervention was reduced by almost 
50% in Group 3. These findings are interesting, in particular, 
because during 450 days of evaluation, none of the therapy groups 
showed CAL. Thus, it can be proclaimed that the supragingival 
control favors the stability of the subgingival area, reinforcing 
its importance. Nevertheless, this subject was also evaluated in 
patients with mucositis [24]. In this study, it was observed that 
the supramucosal biofilm control determines reductions in PPD, 
BOP, and stability of CAL as does the SPG, in the same patients, 
when comparing implants and teeth in a split-mouth design.
A recent study [26] showed the impact of the SPG during 
the periodontal maintenance period (PMP). In a randomized 
clinical trial, 62 patients with moderate-to-severe periodontitis, 
were treated and allocated to receive: 1) only SPG, or 2) SPG plus 
subgingival scaling. During 2 years of PMP it was observed that all 
clinical indicators (plaque and gingivitis indexes, PPD, BOP, and 
CAL) presented improvements or stability, with no intergroup 
differences. These results, corroborating those by Jenkins et al. 
[8], and Heasman et al. [27], suggest that the SPG is essential to 
maintain periodontal heath during the PMP and also interrogate 
the need of subgingival interventions.
Microbiological and immunological analyses were also 
performed with the sample from Gomes et al., 2007 [10]. The 
microbiological investigation used the real-time polymerase 
chain reaction technique to evaluate the behavior of 
subgingival bacteria species during the 6-months-supragingival 
control in periodontitis patients [11]. It was observed that a 
significant decrease of total bacteria (Eubacteria domain) and subgingival species were commonly associated to periodontitis: 
Porphyromonas gingivalis [28-30], Parvimonas micra [29,30], 
Dialister pneumosintes [29,31-33], and Aggregatibacter 
actinomycetemcomitans [34,35]. The immunological analysis, 
exploring only interleukin 1-β from gingival crevicular fluid, 
showed that SPG was able to promote significant reductions of 
this inflammatory indicator over time [23]. In a PhD thesis [36], 
the subgingival microbiological behavior during the first year of 
the PMP [26] was investigated. The results showed no intergroup 
differences in total bacterial counts (Eubacteria domain), as well 
as in the counts of the red complex bacteria (Porphyromonas 
gingivalis, Tannerella forsythia, and Treponema denticola); the 
mean counts of all target species remained at low levels (≤103) 
throughout the study [36].
One of the biggest challenges to the periodontists is to 
establish the maintenance routines, and essentially, to detect 
or decide about the time interval needed by each patient in 
order to maintain therapy results. Lang and Tonetti [37], when 
proposing the periodontal risk assessment (PRA), worked on 
this important subject. The PRA gives information about the level 
of “risk” of the progression of periodontitis, based on clinical, 
systemic, and behavioral individual characteristics of the patient. 
A publication from Butze et al., 2015 [25], uncovered other 
important issue on supragingival studies. Using the PRA, and 
under the hypothesis that the SPG is an important instrument 
to modulate the subgingival environment, the authors showed 
that while changing the subgingival inflammatory pattern, the 
supragingival control alters the risk estimation for progression 
of periodontal destruction. Even though the PRA is not an 
instrument for such investigation, that is, during therapy, the 
results from Butze et al. [25], also revealed the impact that the 
SPG has on the management of a periodontal patient, whether 
during or after therapy.
CONCLUSION
Collectively, these results with the those stated by other 
authors [6,7,38-40], including epidemiological data on 
prevalence of gingivitis [41-43], reinforce the need of a good SPG 
performed both by dentists, in time-interval appointments, and 
patients, under professional orientation, in a daily practice. The 
combination of these supragingival control interventions are 
comprehended as essential in all steps of periodontal care, from 
prevention to periodontal maintenance, passing over the concept 
of the supragingival control as a simple and second-plan step of periodontal interventions.
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